SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

MercadoLibre, Inc. engages in the development of an online commerce platform with a focus on e-commerce and related services. It operates through the following geographical segments: Brazil, Argentina, Mexico, and Other Countries. The Other Countries segment refers to Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Panama, Peru, Bolivia, Honduras, Nicaragua, El Salvador, Guatemala, Paraguay, Uruguay, and the United States of America. Its products provide a mechanism for buying, selling, and paying as well as collecting, generating leads, and comparing lists through e-commerce transactions. The company was founded by Marcos Eduardo Galperin on October 15, 1999 and is headquartered in Montevideo, Uruguay.

MercadoLibre Inc

MercadoLibre is currently trending as investors debate the impact of aggressive reinvestment strategies into logistics and credit portfolio expansion on near-term profit margins. While the community remains divided over the stock's short-term volatility and institutional positioning, many traders are highlighting the company's dominant regional ecosystem and long-term growth potential as a primary catalyst for buying the dip.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Toronto, Canada.

Bank of Montreal - MicroSectors Gold Miners 3X Leveraged ETN

GDXU is experiencing extreme volatility as traders weigh the impact of shifting geopolitical tensions and inflation data on precious metals against aggressive profit-taking. The community is sharply divided, with many debating whether to swing trade the rapid price swings or hold through the current uncertainty in anticipation of a larger gold market rally.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors monitor the early-stage commercial rollout of Yartemlea following recent FDA approval and anticipate the next potential milestone payments from the Novo Nordisk partnership. Community discussion is heavily focused on the stock's recent price volatility, which many long-term shareholders characterize as artificial suppression by short sellers, while they look for signs of sustained revenue growth and upcoming catalysts like EU regulatory updates.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna is experiencing a significant surge in trading volume and price momentum as the community highlights the stock's low float and strategic positioning as a natural gas supplier amidst deepening geopolitical instability in the Middle East. Traders are actively debating the potential for a sustained breakout, with many citing the company's European energy infrastructure assets and recent reports of increased natural gas reserves as key catalysts for current investor interest.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending as investors closely monitor reports of internal frustration within the administration regarding delays in cannabis rescheduling, fueling intense community speculation about an imminent regulatory update. Traders are actively debating the stock's potential as a long-term play on global beverage and cannabis integration versus concerns over dilution and the ongoing wait for federal policy shifts.

ProShares Trust - ProShares UltraShort Silver -2x Shares

ProShares UltraShort Silver

ProShares UltraShort Silver (ZSL) is currently at the center of intense debate as investors weigh the impact of rising margin requirements and fading speculative hype against potential long-term industrial demand for silver. While some traders are aggressively positioning in ZSL to capitalize on a deeper correction in silver prices, others are cautioning against the risks of time decay associated with leveraged ETFs and the potential for a sharp mean-reversion bounce.

Gold.com, Inc. engages in the trading of gold, silver, platinum, and palladium bullion numismatic coins, and related products. It operates through the following segments: Wholesale Trading and Ancillary Services, Direct-to-Consumer, and Secured Lending. The Wholesale Trading and Ancillary Services segment is involved in the distribution and purchasing of metal products from sovereign and private mints. The Direct-to-Consumer segment provides access to a multitude of products through its wholly owned subsidiaries. The Secured Lending segment includes coin and precious metal dealers, investors, and collectors. The company was founded by Steven C. Markoff on April 9, 1965 and is headquartered in El Segundo, CA.

Gold.com Inc.

Investors are currently monitoring $AMRK for its potential as a precious metals platform, particularly following its strategic acquisition of JM Bullion and recent shifts in analyst sentiment. The community is actively debating its valuation versus industry peers as the company navigates ongoing insider activity and precious metals market volatility.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in George Town, Cayman Islands.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is facing downward pressure following political uncertainty in Brazil surrounding the upcoming presidential election, which has triggered a broader sell-off in regional assets. Despite the volatility, the community remains divided between long-term investors highlighting the firm's fundamental growth and U.S. market expansion, and traders frustrated by the stock's repeated inability to sustain momentum.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is generating intense interest as investors weigh its progress toward securing commercial mining permits following a positive regulatory compliance finding from NOAA. While bulls are focused on the company's potential to secure federal funding and corner a domestic supply of critical minerals, others are closely monitoring the stock's volatility and its upcoming earnings call.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP is trending as investors debate the potential impact of the Clarity Act on the token's long-term utility, with the community split between those accumulating at historic lows and others expressing deep frustration over prolonged price suppression. Conversations are currently dominated by intense speculation regarding institutional adoption, the future of the Anvil protocol, and the impact of potential regulatory breakthroughs in the coming months.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Collegium Pharmaceutical (NASDAQ:COLL) EVP Sells 13,976 Shares of Stock

Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Get Free Report) EVP David Dieter sold 13,976 shares of the firm's stock in a transaction dated Wednesday, March 18th. The shares were sold at an average...

Collegium Pharmaceutical (NASDAQ:COLL) Given Buy Rating at HC Wainwright

HC Wainwright reissued a "buy" rating and set a $60.00 target price on shares of Collegium Pharmaceutical in a research report on Friday...

Needham & Company LLC Reiterates Buy Rating for Collegium Pharmaceutical (NASDAQ:COLL)

Needham & Company LLC reaffirmed a "buy" rating and set a $56.00 target price (up from $54.00) on shares of Collegium Pharmaceutical in a report on Thursday...

Collegium Pharmaceutical (NASDAQ:COLL) Shares Gap Up   - Should You Buy?

Collegium Pharmaceutical (NASDAQ:COLL) Shares Gap Up - Still a Buy...

Collegium Pharmaceutical to Buy AZSTARYS for $650M, Expanding ADHD Franchise Through 2037

Collegium Pharmaceutical (NASDAQ:COLL) outlined plans to acquire the ADHD drug AZSTARYS and related corporate subsidiaries from Corium Therapeutics, a transaction the company said would add a second commercial-stage ADHD product alongside Jornay PM and extend the durability of its ADHD revenue base...

Collegium Pharmaceutical To Acquire AZSTARYS For At Least $650 Mln From Corium Therapeutics

(RTTNews) - Collegium Pharmaceutical, Inc. (COLL), a biopharmaceutical company, Thursday announced that it has agreed to acquire AZSTARYS for $650 million in cash from Corium Therapeutics Holdings, a...

Collegium Pharmaceutical, Inc. $COLL Position Reduced by Eventide Asset Management LLC

Eventide Asset Management LLC trimmed its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 9.5% in the third quarter, according to its most recent disclosure with the...

Collegium Pharmaceutical touts record 2025, sees JORNAY PM driving 2026 growth at Barclays Miami Conference

Collegium Pharmaceutical (NASDAQ:COLL) highlighted a record-breaking 2025 and outlined its 2026 outlook at the Barclays Miami Conference, emphasizing strong performance from newly acquired ADHD...

Jefferies Financial Group Inc. Takes $4.43 Million Position in Collegium Pharmaceutical, Inc. $COLL

Jefferies Financial Group Inc. acquired a new position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with...

Citigroup Inc. Decreases Stock Holdings in Collegium Pharmaceutical, Inc. $COLL

Citigroup Inc. trimmed its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL - Free Report) by 97.5% in the third quarter, according to its most recent filing with the Securities and...

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.

COLL
Collegium Pharmaceutical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest COLL News

COLLCollegium Pharmaceutical Inc